Literature DB >> 10217058

Criteria and recommendations for vitamin C intake.

M Levine1, S C Rumsey, R Daruwala, J B Park, Y Wang.   

Abstract

Recommendations for vitamin C intake are under revision by the Food and Nutrition Board of the National Academy of Sciences. Since 1989 when the last recommended dietary allowance (RDA) of 60 mg was published, extensive biochemical, molecular, epidemiologic, and clinical data have become available. New recommendations can be based on the following 9 criteria: dietary availability, steady-state concentrations in plasma in relationship to dose, steady-state concentrations in tissues in relationship to dose, bioavailability, urine excretion, adverse effects, biochemical and molecular function in relationship to vitamin concentration, direct beneficial effects and epidemiologic observations in relationship to dose, and prevention of deficiency. We applied these criteria to the Food and Nutrition Board's new guidelines, the Dietary Reference Intakes, which include 4 reference values. The estimated average requirement (EAR) is the amount of nutrient estimated to meet the requirement of half the healthy individuals in a life-stage and gender group. Based on an EAR of 100 mg/d of vitamin C, the RDA is proposed to be 120 mg/d. If the EAR cannot be determined, an adequate intake (AI) amount is recommended instead of an RDA. The AI was estimated to be either 200 mg/d from 5 servings of fruits and vegetables or 100 mg/d of vitamin C to prevent deficiency with a margin of safety. The final classification, the tolerable upper intake level, is the highest daily level of nutrient intake that does not pose risk or adverse health effects to almost all individuals in the population. This amount is proposed to be less than 1 g of vitamin C daily. Physicians can tell patients that 5 servings of fruits and vegetables per day may be beneficial in preventing cancer and providing sufficient vitamin C intake for healthy people, and that 1 g or more of vitamin C may have adverse consequences in some people.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217058     DOI: 10.1001/jama.281.15.1415

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  98 in total

Review 1.  New insights into the physiology and pharmacology of vitamin C.

Authors:  S J Padayatty; M Levine
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

Authors:  L J Hoffer
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

Review 3.  Complementary alternative medicine and nuclear medicine.

Authors:  Ursula Werneke; V Ralph McCready
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

4.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 5.  Vitamin C may affect lung infections.

Authors:  Harri Hemilä; Pekka Louhiala
Journal:  J R Soc Med       Date:  2007-11       Impact factor: 5.344

6.  Micronutrient Status in Diabetic Patients with Foot Ulcers.

Authors:  Guilherme Pena; Beatrice Kuang; Prue Cowled; Stuart Howell; Joseph Dawson; Ross Philpot; Robert Fitridge
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-06       Impact factor: 4.730

Review 7.  Rheumatic manifestations of scurvy.

Authors:  Claudia Ferrari; Niccolò Possemato; Nicolò Pipitone; Bernhard Manger; Carlo Salvarani
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

8.  Breaking down, starting up: can a vitamin C-enriched gelatin supplement before exercise increase collagen synthesis?

Authors:  Mark Levine; Pierre-Christian Violet
Journal:  Am J Clin Nutr       Date:  2016-12-21       Impact factor: 7.045

9.  Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Stavros G Drakos; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2020-06-18       Impact factor: 2.969

10.  Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Authors:  Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.